JP2017106923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017106923A5 JP2017106923A5 JP2016243869A JP2016243869A JP2017106923A5 JP 2017106923 A5 JP2017106923 A5 JP 2017106923A5 JP 2016243869 A JP2016243869 A JP 2016243869A JP 2016243869 A JP2016243869 A JP 2016243869A JP 2017106923 A5 JP2017106923 A5 JP 2017106923A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- protein
- sample
- treatment
- modulator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32571710P | 2010-04-19 | 2010-04-19 | |
| US61/325,717 | 2010-04-19 | ||
| US35649510P | 2010-06-18 | 2010-06-18 | |
| US61/356,495 | 2010-06-18 | ||
| US42117810P | 2010-12-08 | 2010-12-08 | |
| US61/421,178 | 2010-12-08 | ||
| US201161443146P | 2011-02-15 | 2011-02-15 | |
| US61/443,146 | 2011-02-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Division JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017106923A JP2017106923A (ja) | 2017-06-15 |
| JP2017106923A5 true JP2017106923A5 (OSRAM) | 2017-09-14 |
| JP6580546B2 JP6580546B2 (ja) | 2019-09-25 |
Family
ID=44834747
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Expired - Fee Related JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
| JP2016243869A Expired - Fee Related JP6580546B2 (ja) | 2010-04-19 | 2016-12-16 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Expired - Fee Related JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9766249B2 (OSRAM) |
| EP (1) | EP2561368B1 (OSRAM) |
| JP (2) | JP6158078B2 (OSRAM) |
| KR (1) | KR101977875B1 (OSRAM) |
| CN (2) | CN108535465A (OSRAM) |
| AU (1) | AU2011242990B2 (OSRAM) |
| CA (1) | CA2795362C (OSRAM) |
| ES (1) | ES2650674T3 (OSRAM) |
| HK (1) | HK1258688A1 (OSRAM) |
| PL (1) | PL2561368T3 (OSRAM) |
| SG (1) | SG184507A1 (OSRAM) |
| WO (1) | WO2011133477A2 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0913578A2 (pt) | 2008-05-14 | 2017-06-06 | Dermtech Int | diagnose de melanoma e lentigo solar por análise de ácido nucléico |
| CA2767616A1 (en) | 2009-07-09 | 2011-01-13 | The Scripps Research Institute | Gene expression profiles associated with chronic allograft nephropathy |
| WO2014145705A2 (en) | 2013-03-15 | 2014-09-18 | Battelle Memorial Institute | Progression analytics system |
| CN104152397A (zh) * | 2013-05-13 | 2014-11-19 | 复旦大学 | 一种致敏动物的脾细胞模型及其在药物筛选中的用途 |
| GB201314485D0 (en) * | 2013-08-13 | 2013-09-25 | Electrophoretics Ltd | Materials and methods relating to pancreatic cancer |
| EP3052129A2 (en) * | 2013-09-30 | 2016-08-10 | Daiichi Sankyo Company, Limited | Protein biomarker and uses thereof |
| US10443100B2 (en) | 2014-05-22 | 2019-10-15 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
| US11104951B2 (en) | 2014-05-22 | 2021-08-31 | The Scripps Research Institute | Molecular signatures for distinguishing liver transplant rejections or injuries |
| CN104745700A (zh) * | 2015-03-27 | 2015-07-01 | 南京医科大学 | 一种食管癌相关甲基化生物标志物及应用 |
| JP6910339B2 (ja) * | 2015-07-07 | 2021-07-28 | ジェネンテック， インコーポレイテッド | 抗ｈｅｒ２抗体−薬物複合体とｂｃｌ−２阻害剤の併用療法 |
| WO2017136603A1 (en) * | 2016-02-02 | 2017-08-10 | Guardant Health, Inc. | Cancer evolution detection and diagnostic |
| CN105524973A (zh) * | 2016-03-15 | 2016-04-27 | 南京华奥生物医药技术有限公司 | 利用自体肿瘤与正常配对原代细胞筛选肿瘤药物的方法 |
| CN107091930B (zh) * | 2017-03-07 | 2020-09-15 | 杭州百凌生物科技有限公司 | 快速预测和提高非小细胞肺癌细胞对表皮细胞生长因子受体抑制剂敏感性的方法 |
| CN107271672B (zh) * | 2017-06-21 | 2019-01-01 | 首都医科大学附属北京友谊医院 | 外泌体p-ERK在制备结直肠癌诊断产品中的应用 |
| KR102094802B1 (ko) * | 2017-10-24 | 2020-03-31 | 고려대학교 산학협력단 | 소변 대사체 분석을 이용한 베체트병의 진단방법 |
| US20200325543A1 (en) * | 2017-11-20 | 2020-10-15 | Tolremo Therapeutics Ag | Diagnostic method |
| TWI683905B (zh) * | 2017-11-21 | 2020-02-01 | 長庚醫療財團法人高雄長庚紀念醫院 | 用於檢測川崎氏病的方法及套組以及用於治療川崎氏病的方法 |
| US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
| AU2020247911A1 (en) | 2019-03-26 | 2021-11-11 | Dermtech, Llc | Novel gene classifiers and uses thereof in skin cancers |
| KR102199141B1 (ko) | 2019-05-03 | 2021-01-06 | 사회복지법인 삼성생명공익재단 | 대장암 진단 마커 및 대장암 진단에 필요한 정보를 제공하는 방법 |
| GB201914517D0 (en) * | 2019-10-08 | 2019-11-20 | Randox Laboratories Ltd | Xbp1 isoform multiplex assay |
| JP2023537260A (ja) * | 2020-07-24 | 2023-08-31 | ジェネンテック， インコーポレイテッド | バイオマーカーを使用する骨髄穿刺液の血液希釈の決定 |
| US20240167102A1 (en) * | 2021-03-02 | 2024-05-23 | Dermtech, Inc. | Predicting therapeutic response |
| CN115267165A (zh) * | 2022-08-15 | 2022-11-01 | 海仕兰(上海)生物科技有限公司 | 一种悬浮芯片系统及其应用以及基于悬浮芯片系统对肿瘤伴随诊断因子检测方法 |
| KR20240037082A (ko) * | 2022-09-14 | 2024-03-21 | 아주대학교산학협력단 | 항암제 내성 측정용 바이오 마커 및 이를 이용한 항암제 내성 예측 정보 제공 방법 |
| CN118130793B (zh) * | 2024-02-26 | 2025-07-29 | 赣南医科大学 | 视网膜母细胞瘤的生物标志物cdk12及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| WO2006026710A2 (en) * | 2004-08-31 | 2006-03-09 | The Johns Hopkins University | Rapid prognostic assay for malignancies treated with epidermal growth factor receptor |
| KR101381331B1 (ko) | 2005-05-09 | 2014-04-04 | 테라노스, 인코포레이티드 | 현장진료 유체 시스템 및 그 용도 |
| JP5208730B2 (ja) * | 2005-05-18 | 2013-06-12 | ノバルティス アーゲー | Ｃｄ４０シグナル伝達によって媒介される増殖性障害の診断および治療のための方法 |
| CN101194027B (zh) | 2005-06-08 | 2012-10-24 | 日立化成研究中心公司 | 用于基于瘤细胞及受刺激的白细胞内mRNA表达谱而预测对肿瘤疾病的免疫应答的方法 |
| WO2007028005A2 (en) | 2005-09-01 | 2007-03-08 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| WO2007143183A2 (en) | 2006-06-04 | 2007-12-13 | Soner Altiok | Methods for developing and assessing therapeutic agents |
| EP2899541A1 (en) * | 2007-03-02 | 2015-07-29 | Genentech, Inc. | Predicting response to a HER dimerisation inhbitor based on low HER3 expression |
| US20090098594A1 (en) * | 2007-08-21 | 2009-04-16 | Nodality, Inc. | Methods for diagnosis prognosis and methods of treatment |
| EP2210080B1 (en) | 2007-10-24 | 2015-01-28 | Biomarker Strategies, Llc | Improved methods and devices for cellular analysis |
| WO2009073513A1 (en) * | 2007-11-30 | 2009-06-11 | Schering Corporation | Braf biomarkers |
-
2011
- 2011-04-18 AU AU2011242990A patent/AU2011242990B2/en not_active Ceased
- 2011-04-18 SG SG2012074746A patent/SG184507A1/en unknown
- 2011-04-18 KR KR1020127029888A patent/KR101977875B1/ko not_active Expired - Fee Related
- 2011-04-18 WO PCT/US2011/032935 patent/WO2011133477A2/en not_active Ceased
- 2011-04-18 PL PL11772505T patent/PL2561368T3/pl unknown
- 2011-04-18 JP JP2013506214A patent/JP6158078B2/ja not_active Expired - Fee Related
- 2011-04-18 US US13/089,219 patent/US9766249B2/en not_active Expired - Fee Related
- 2011-04-18 CN CN201810296066.8A patent/CN108535465A/zh active Pending
- 2011-04-18 CA CA2795362A patent/CA2795362C/en active Active
- 2011-04-18 ES ES11772505.1T patent/ES2650674T3/es active Active
- 2011-04-18 CN CN201180030332.9A patent/CN102947706B/zh not_active Expired - Fee Related
- 2011-04-18 EP EP11772505.1A patent/EP2561368B1/en active Active
-
2016
- 2016-12-16 JP JP2016243869A patent/JP6580546B2/ja not_active Expired - Fee Related
-
2019
- 2019-01-22 HK HK19101066.6A patent/HK1258688A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yankaskas et al. | A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens | |
| Liu et al. | DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways | |
| Grottke et al. | Downregulation of AKT3 increases migration and metastasis in triple negative breast cancer cells by upregulating S100A4 | |
| Xia et al. | Exosome‐mediated transfer of miR‐1260b promotes cell invasion through Wnt/β–catenin signaling pathway in lung adenocarcinoma | |
| Sharif et al. | Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling | |
| CN102947706B (zh) | 预测药物敏感性、抗性和疾病进展的组合物和方法 | |
| JP2016507233A5 (OSRAM) | ||
| Miyamoto et al. | Single-cell analysis of circulating tumor cells as a window into tumor heterogeneity | |
| Bhandari et al. | MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines | |
| Lin et al. | Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway | |
| Yan et al. | LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion | |
| ES2959649T3 (es) | Detección temprana del cáncer de pulmón mediante fenotipación por metilación del ADN de células derivadas del esputo | |
| Suri et al. | Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach | |
| Qu et al. | Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression | |
| CN104805197A (zh) | 分子标志物用于乳腺癌诊断和预后评估的方法 | |
| JP2015210268A5 (OSRAM) | ||
| Jeong et al. | Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion | |
| Riccardo et al. | Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers | |
| Yang et al. | RETRACTED ARTICLE: Long Noncoding RNA KCNMB2-AS1 Increases ROCK1 Expression by Sponging microRNA-374a-3p to Facilitate the Progression of Non–Small-Cell Lung Cancer | |
| Bai et al. | Prognostic significance of HER2 status evaluation using immunohistochemistry in patients with urothelial carcinoma of the bladder: A retrospective single‑center experience | |
| Jin et al. | Endoplasmic reticulum–resident protein Sec62 drives colorectal cancer metastasis via MAPK/ATF2/UCA1 axis | |
| Steen et al. | Expression analysis of SOX2 and SOX9 in patients with oral squamous cell carcinoma | |
| Wu et al. | Biomarkers of lymph node metastasis in esophageal cancer | |
| ES2891795T3 (es) | Procedimiento y kit para el diagnóstico de cáncer colorrectal | |
| Bahadoran et al. | Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications |